港股異動 | 波司登(3998.HK)漲5% 預計年度純利同比增長約40%
格隆匯4月12日丨波司登(3998.HK)現報3.98港元, 漲5.01%,暫成交3850萬港元,最新總市值429億港元。波司登上週五(9日)晚間公佈,公司預期截至2021年3月31日止年度("2020/2021財年")的收入和公司權益持有人應占利潤較截至2020年3月31日止年度同期分別約有10%-15%和約40%的增長。期內,集團堅持"聚焦主航道、聚焦主品牌"戰略目標不動搖,通過新零售能力建設、商品一體化能力建設,集團的品牌羽絨服業務板塊較去年同期錄得持續健康增長。同時,由於品牌羽絨服業務板塊的品牌升級效果凸顯,加之成本管控效果理想,預期集團的毛利率有約3個百分點的提升空間。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.